Works by Tomašič, Tihomir
Results: 49
Novel Scaffolds for Modulation of NOD2 Identified by Pharmacophore-Based Virtual Screening.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 8, p. 1054, doi. 10.3390/biom12081054
- By:
- Publication type:
- Article
In Silico Discovery and Optimisation of a Novel Structural Class of Hsp90 C-Terminal Domain Inhibitors.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 7, p. N.PAG, doi. 10.3390/biom12070884
- By:
- Publication type:
- Article
Virtual Screening Assisted Search for Inhibitors of the Translocated Intimin Receptor of Enteropathogenic Escherichia Coli.
- Published in:
- ChemBioChem, 2024, v. 25, n. 2, p. 1, doi. 10.1002/cbic.202300638
- By:
- Publication type:
- Article
A New Cell‐Based AI‐2‐Mediated Quorum Sensing Interference Assay in Screening of LsrK‐Targeted Inhibitors.
- Published in:
- ChemBioChem, 2020, v. 21, n. 13, p. 1918, doi. 10.1002/cbic.201900773
- By:
- Publication type:
- Article
Design, synthesis, and biological evaluation of 1-ethyl-3-(thiazol-2-yl)urea derivatives as Escherichia coli DNA gyrase inhibitors.
- Published in:
- Archiv der Pharmazie, 2018, v. 351, n. 1, p. n/a, doi. 10.1002/ardp.201700333
- By:
- Publication type:
- Article
Peptide microarray analysis of the cross-talk between O-Glc NAcylation and tyrosine phosphorylation.
- Published in:
- FEBS Letters, 2017, v. 591, n. 13, p. 1872, doi. 10.1002/1873-3468.12708
- By:
- Publication type:
- Article
Overcoming challenges of HERG potassium channel liability through rational design: Eag1 inhibitors for cancer treatment.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 1, p. 183, doi. 10.1002/med.21808
- By:
- Publication type:
- Article
Discovery of K<sub>V</sub>1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges.
- Published in:
- Medicinal Research Reviews, 2021, v. 41, n. 4, p. 2423, doi. 10.1002/med.21800
- By:
- Publication type:
- Article
Efflux pump inhibitors of clinically relevant multidrug resistant bacteria.
- Published in:
- Medicinal Research Reviews, 2019, v. 39, n. 6, p. 2460, doi. 10.1002/med.21591
- By:
- Publication type:
- Article
Comparative evaluation of several docking tools for docking small molecule ligands to DC-SIGN.
- Published in:
- Journal of Molecular Modeling, 2015, v. 21, n. 6, p. 1, doi. 10.1007/s00894-015-2713-2
- By:
- Publication type:
- Article
Marine alkaloid oroidin analogues with antiviral potential: A novel class of synthetic compounds targeting the cellular chaperone Hsp90.
- Published in:
- Chemical Biology & Drug Design, 2017, v. 90, n. 6, p. 1147, doi. 10.1111/cbdd.13034
- By:
- Publication type:
- Article
Design of OSMI‐4 Analogs Using Scaffold Hopping: Investigating the Importance of the Uridine Mimic in the Binding of OGT Inhibitors.
- Published in:
- ChemMedChem, 2023, v. 18, n. 8, p. 1, doi. 10.1002/cmdc.202300001
- By:
- Publication type:
- Article
Selective Galectin‐8N Ligands: The Design and Synthesis of Phthalazinone‐d‐Galactals.
- Published in:
- ChemMedChem, 2022, v. 17, n. 6, p. 1, doi. 10.1002/cmdc.202100575
- By:
- Publication type:
- Article
Front Cover: Selective Monovalent Galectin‐8 Ligands Based on 3‐Lactoylgalactoside (ChemMedChem 3/2022)
- Published in:
- ChemMedChem, 2022, v. 17, n. 3, p. 1, doi. 10.1002/cmdc.202200044
- By:
- Publication type:
- Article
Front Cover: Selective Monovalent Galectin‐8 Ligands Based on 3‐Lactoylgalactoside (ChemMedChem 3/2022).
- Published in:
- ChemMedChem, 2022, v. 17, n. 3, p. 1, doi. 10.1002/cmdc.202100514
- By:
- Publication type:
- Article
Selective Monovalent Galectin‐8 Ligands Based on 3‐Lactoylgalactoside.
- Published in:
- ChemMedChem, 2022, v. 17, n. 3, p. 1, doi. 10.1002/cmdc.202100514
- By:
- Publication type:
- Article
A Potent N‐(piperidin‐4‐yl)‐1H‐pyrrole‐2‐carboxamide Inhibitor of Adenylyl Cyclase of G. lamblia: Biological Evaluation and Molecular Modelling Studies.
- Published in:
- ChemMedChem, 2021, v. 16, n. 13, p. 2094, doi. 10.1002/cmdc.202100037
- By:
- Publication type:
- Article
Radiolabelled CCK<sub>2</sub>R Antagonists Containing PEG Linkers: Design, Synthesis and Evaluation.
- Published in:
- ChemMedChem, 2021, v. 16, n. 1, p. 155, doi. 10.1002/cmdc.202000392
- By:
- Publication type:
- Article
Privileged Structures in Drug Discovery. Edited by Larry Yet.
- Published in:
- ChemMedChem, 2020, v. 15, n. 8, p. 726, doi. 10.1002/cmdc.202000095
- By:
- Publication type:
- Article
Cover Feature: Dual Escherichia coli DNA Gyrase A and B Inhibitors with Antibacterial Activity (ChemMedChem 3/2020).
- Published in:
- ChemMedChem, 2020, v. 15, n. 3, p. 264, doi. 10.1002/cmdc.202000031
- By:
- Publication type:
- Article
Dual Escherichia coli DNA Gyrase A and B Inhibitors with Antibacterial Activity.
- Published in:
- ChemMedChem, 2020, v. 15, n. 3, p. 265, doi. 10.1002/cmdc.201900607
- By:
- Publication type:
- Article
Inhibition of Hepatitis C Replication by Targeting the Molecular Chaperone Hsp90: Synthesis and Biological Evaluation of 4,5,6,7‐Tetrahydrobenzo[1,2‐d]thiazole Derivatives.
- Published in:
- ChemMedChem, 2019, v. 14, n. 3, p. 334, doi. 10.1002/cmdc.201800724
- By:
- Publication type:
- Article
Synthesis and Evaluation of <italic>N</italic>‐Phenylpyrrolamides as DNA Gyrase B Inhibitors.
- Published in:
- ChemMedChem, 2018, v. 13, n. 2, p. 186, doi. 10.1002/cmdc.201700549
- By:
- Publication type:
- Article
Structure-Function Studies of Sponge-Derived Compounds on the Cardiac Ca V 3.1 Channel.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 3429, doi. 10.3390/ijms24043429
- By:
- Publication type:
- Article
Molecular Dynamics-Derived Pharmacophore Model Explaining the Nonselective Aspect of K V 10.1 Pore Blockers.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 16, p. 8999, doi. 10.3390/ijms22168999
- By:
- Publication type:
- Article
Discovery of Novel Hsp90 C-Terminal Inhibitors Using 3D-Pharmacophores Derived from Molecular Dynamics Simulations.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 18, p. 6898, doi. 10.3390/ijms21186898
- By:
- Publication type:
- Article
Rational design of balanced dual-targeting antibiotics with limited resistance.
- Published in:
- PLoS Biology, 2020, v. 18, n. 10, p. 1, doi. 10.1371/journal.pbio.3000819
- By:
- Publication type:
- Article
Discovery of a New Drug-like Series of OGT Inhibitors by Virtual Screening.
- Published in:
- Molecules, 2022, v. 27, n. 6, p. 1996, doi. 10.3390/molecules27061996
- By:
- Publication type:
- Article
Intracellular Hydrolysis of Small-Molecule O-Linked N-Acetylglucosamine Transferase Inhibitors Differs among Cells and Is Not Required for Its Inhibition.
- Published in:
- Molecules, 2020, v. 25, n. 15, p. 3381, doi. 10.3390/molecules25153381
- By:
- Publication type:
- Article
Nanomolar inhibitor of the galectin-8 N-terminal domain binds via a non-canonical cation-π interaction.
- Published in:
- Communications Chemistry, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s42004-025-01458-6
- By:
- Publication type:
- Article
New Diarylamine K V 10.1 Inhibitors and Their Anticancer Potential.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/pharmaceutics14091963
- By:
- Publication type:
- Article
Structure-Activity Relationships of Benzothiazole-Based Hsp90 C-Terminal-Domain Inhibitors.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 8, p. 1283, doi. 10.3390/pharmaceutics13081283
- By:
- Publication type:
- Article
Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 5, p. 762, doi. 10.3390/pharmaceutics13050762
- By:
- Publication type:
- Article
The Road to Better Management in Resistant Hypertension—Diagnostic and Therapeutic Insights.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 5, p. 714, doi. 10.3390/pharmaceutics13050714
- By:
- Publication type:
- Article
Plumbagin Elicits Cell-Specific Cytotoxic Effects and Metabolic Responses in Melanoma Cells.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 5, p. 706, doi. 10.3390/pharmaceutics13050706
- By:
- Publication type:
- Article
Is it Worth Combining Solidago virgaurea Extract and Antibiotics against Uropathogenic Escherichia coli rods? An In Vitro Model Study.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 4, p. 573, doi. 10.3390/pharmaceutics13040573
- By:
- Publication type:
- Article
Anticancer Activity of Triazolo-Thiadiazole Derivatives and Inhibition of AKT1 and AKT2 Activation.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 4, p. 493, doi. 10.3390/pharmaceutics13040493
- By:
- Publication type:
- Article
Cathepsin S Cleaves BAX as a Novel and Therapeutically Important Regulatory Mechanism for Apoptosis.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 3, p. 339, doi. 10.3390/pharmaceutics13030339
- By:
- Publication type:
- Article
A Novel Follitropin Analog Inhibits Follitropin Activity In Vitro.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 3, p. 325, doi. 10.3390/pharmaceutics13030325
- By:
- Publication type:
- Article
Synergistic Effects of Propolis Combined with 2-Phenoxyethanol and Antipyretics on the Growth of Staphylococcus aureus.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 2, p. 215, doi. 10.3390/pharmaceutics13020215
- By:
- Publication type:
- Article
Hybrid Inhibitors of DNA Gyrase A and B: Design, Synthesis and Evaluation.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 1, p. 6, doi. 10.3390/pharmaceutics13010006
- By:
- Publication type:
- Article
Selective DNA Gyrase Inhibitors: Multi-Target in Silico Profiling with 3D-Pharmacophores.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 8, p. 789, doi. 10.3390/ph14080789
- By:
- Publication type:
- Article
High-performance liquid chromatography evaluation of lipophilicity and QSRR modeling of a series of dual DNA gyrase and topoisomerase IV inhibitors.
- Published in:
- Acta Chromatographica, 2024, v. 36, n. 1, p. 45, doi. 10.1556/1326.2022.01096
- By:
- Publication type:
- Article
Evaluation of Michael-type Acceptor Reactivity of 5-Benzylidenebarbiturates, 5-benzylidenerhodanines, and Related Heterocycles Using NMR.
- Published in:
- Acta Chimica Slovenica, 2014, v. 61, n. 3, p. 637
- By:
- Publication type:
- Article
Correction: Gubič et al. Design of New Potent and Selective Thiophene-Based K V 1.3 Inhibitors and Their Potential for Anticancer Activity. Cancers 2022, 14 , 2595.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Design of New Potent and Selective Thiophene-Based K V 1.3 Inhibitors and Their Potential for Anticancer Activity.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2595, doi. 10.3390/cancers14112595
- By:
- Publication type:
- Article
3D Pharmacophore-Based Discovery of Novel K V 10.1 Inhibitors with Antiproliferative Activity.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1244, doi. 10.3390/cancers13061244
- By:
- Publication type:
- Article
Targeting N -Acetylglucosaminidase in Staphylococcus aureus with Iminosugar Inhibitors.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 8, p. 751, doi. 10.3390/antibiotics13080751
- By:
- Publication type:
- Article
OVERVIEW OF ANTIVIRAL DRUGS AGAINST SARS-CoV-2 FOR THE TREATMENT OF COVID-19.
- Published in:
- Acta Medica Medianae, 2021, v. 60, n. 1, p. 5, doi. 10.5633/amm.2021.0101
- By:
- Publication type:
- Article